Roche

Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
climate change
natural disasters
tropical diseases
Takeda
AbbVie
Roche
Flag link:
Pharma companies clear the R&D decks in Q4
Pharma companies clear the R&D decks in Q4
Pharmaforum
R&D
GSK
Sanofi
Eli Lilly
Roche
Gilead Sciences
Flag link:
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Genentech
Roche
idiopathic pulmonary fibrosis
Esbriet
generics
Flag link:
Roche seeks FDA approval for Kadcyla in HER2-positive early breast cancer
Roche seeks FDA approval for Kadcyla in HER2-positive early breast cancer
Pharmaceutical Business Review
Roche
FDA
Kadcyla
HER2-positive early breast cancer
Flag link:
Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance
Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance
Yahoo/Zacks.com
Roche
earnings
Flag link:
Report: five companies would take brunt of Trump Part B proposal
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Donald Trump
Medicare Part B
Amgen
Regeneron
Bristol-Myers Squibb
Genentech
Roche
Flag link:
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Roche
Alzheimer's disease
clinical trials
AC Immune
crenezumab
Biogen
aducanumab
Flag link:
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Imbruvica
Janssen
AbbVie
Roche
Gazyva
chronic lymphocytic leukemia
small lymphocytic lymphoma
FDA
Flag link:
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Endpoints
Genentech
Roche
Alexander Hardy
Pharma CEOs
Flag link:
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
CP WIre
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
Flag link:
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
Flag link:
Roche says 'no thanks' to megadeals, but don't count out smaller M&A
Roche says 'no thanks' to megadeals, but don't count out smaller M&A
Fierce Pharma
Roche
M&A
Christoph Franz
Flag link:
FDA Approves 17th Biosimilar, Third for Herceptin
FDA Approves 17th Biosimilar, Third for Herceptin
RAPS.org
FDA
Merck
Samsung Bioepis
Ontruzant
biosimilars
Roche
Herceptin
Flag link:
Phoenix, Roche partner to develop TNBC biomarker
Phoenix, Roche partner to develop TNBC biomarker
BioCentury
Roche
Phoenix Molecular Designs
diagnostics
molecular diagnostics
triple negative breast cancer
biomarkers
Flag link:
NASH Space in Focus in 2019 as Firms Look to Diversify
NASH Space in Focus in 2019 as Firms Look to Diversify
Yahoo/Zacks.com
NASH
Gilead Sciences
Merck
Roche
Novartis
Jecure Therapeutics
Pfizer
Celgene
Eli Lilly
Flag link:
Genentech Cutting More Jobs in Bay Area
Genentech Cutting More Jobs in Bay Area
BioSpace
Genentech
Roche
layoffs
Bay Area
Flag link:
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Flag link:
Merck taps Roche for Keytruda companion diagnostic
Merck taps Roche for Keytruda companion diagnostic
Medtech Dive
Merck
Roche
solid tumors
oncology
biomarkers
companion diagnostics
diagnostics
Flag link:

Pages